JAGSONPAL Pharmaceuticals Ltd. announced that Mr. Govind Deo, Mr. Bharat Sing and Mr. Ishpal Singh Ghai has been appointed as additional directors and Mr. A C Chakrabottti and Mr. Sukumar Mukhopadhyay resigned from the directorship of the company.

JAGSONPAL Pharmaceuticals Ltd. announced that Company Secretary Mr. S. K. Mata, F.C.S. has resigned from his post and Mr. Raj Kaumar Kapoor has been appointed as Compliance officer cum Company Secretary with effect from March 20, 2013.

JAGSONPAL Pharmaceuticals Ltd. reported unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales/income from operations of INR 491.212 million compared to INR 485.957 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 28.713 million compared to INR 40.171 million a year ago. Profit from ordinary activities before tax was INR 15.540 million compared to INR 31.746 million a year ago. Net profit was INR 10.840 million or INR 0.41 basic and diluted per share compared to INR 23.223 million or INR 0.89 basic and diluted per share a year ago. For the nine months period, the company reported net sales/income from operations of INR 1,282.314 million compared to INR 1,350.520 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 61.833 million compared to INR 110.727 million a year ago. Profit from ordinary activities before tax was INR 24.540 million compared to INR 64.089 million a year ago. Net profit was INR 15.040 million or INR 0.57 basic and diluted per share compared to INR 65.165 million or INR 2.49 basic and diluted per share a year ago.